EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Lifestyle Intervention During Pregnancy Is Associated With Favourable Changes of Vitronectin in Women With Obesity: Results From the Randomised LiP Trial

Birgitte Moeller Luef iD, Katrine Sølling Borlund Mortensen iD, Lasse Møllegaard Obel iD, Louise Laage Stentebjerg iD, Per Glud Ovesen iD, Patrick M Catalano iD, Jan Stener Jørgensen iD, Dorte Møller Jensen iD, Christina Anne Vinter iD, Martin Overgaard iD

Clinical Obesity · 2026-06 · 16 (3)

DOI: 10.1111/cob.70085 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Obesity, online erschienen am 21.05.2026. Verfasst von Birgitte Moeller Luef und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Vitronectin, Life Style, Obesity, Pregnancy Complications. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity in pregnancy is a well‐established risk factor for adverse maternal and neonatal outcomes, including gestational diabetes mellitus (GDM). This study aimed to examine the effects of lifestyle intervention during pregnancy on the cardio‐metabolic protein profile and its association with maternal and neonatal health. The Lifestyle in Pregnancy (LiP) study was a randomised controlled trial conducted between 2007 and 2010 in Denmark. It included 360 pregnant women with obesity (BMI 30–45 kg/m 2 ), aged 18–40 years, who were allocated to either a lifestyle intervention (dietary counselling, physical activity program, free fitness club membership) or standard care. Fasting serum samples from 303 women were collected at 12–15 and 28–30 weeks' gestation and analysed using a 26‐plex cardio‐metabolic proteomics assay. When comparing the cardio‐metabolic protein profiles between the intervention and control groups before and after the intervention in pregnancy, we found that in late pregnancy the levels of two proteins, vitronectin and vitamin D‐binding protein, were significantly lower in the intervention group. In the total cohort, elevated vitronectin was associated with a higher risk of GDM (adjusted odds ratio = 1.45 (95% CI: 1.06–1.98), p = 0.02) and neonatal intensive care unit (NICU) admissions (adjusted odds ratio = 1.68 (95% CI: 1.03–2.73), p = 0.037). Vitronectin may represent a modifiable biomarker linked to metabolic dysfunction in pregnant women with obesity, suggesting a potential underlying pathway by which lifestyle interventions could improve pregnancy outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitronectinLife StyleObesityPregnancy ComplicationsHumansFemalePregnancyAdultYoung AdultDiabetes, GestationalDenmarkAdolescentExercisePregnancy Outcome

Stichwörter der Autor:innen

gestational diabetes mellituslifestyle interventionobesity in pregnancyvitronectin

Substanzen

Vitronectin

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Clinical Biochemistry, Odense University Hospital, Odense, Denmark.
  • Department of Cardiothoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark.
  • Department of Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark.
  • Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark.

ORCID-Profile: Birgitte Moeller Luef, Katrine Sølling Borlund Mortensen, Lasse Møllegaard Obel, Louise Laage Stentebjerg, Per Glud Ovesen, Patrick M Catalano, Jan Stener Jørgensen, Dorte Møller Jensen, Christina Anne Vinter, Martin Overgaard

Zitieren

APA

Luef, B. M., Mortensen, K. S. B., Obel, L. M., Stentebjerg, L. L., Ovesen, P. G., Catalano, P. M., Jørgensen, J. S., Jensen, D. M., Vinter, C. A., & Overgaard, M. (2026). Lifestyle Intervention During Pregnancy Is Associated With Favourable Changes of Vitronectin in Women With Obesity: Results From the Randomised LiP Trial. Clinical Obesity, 16(3). https://doi.org/10.1111/cob.70085

Vancouver

Luef BM, Mortensen KSB, Obel LM, Stentebjerg LL, Ovesen PG, Catalano PM, et al. Lifestyle Intervention During Pregnancy Is Associated With Favourable Changes of Vitronectin in Women With Obesity: Results From the Randomised LiP Trial. Clinical Obesity. 2026;16(3). doi:10.1111/cob.70085

BibTeX
@article{Luef2026,
  author = {Luef, Birgitte Moeller and Mortensen, Katrine Sølling Borlund and Obel, Lasse Møllegaard and Stentebjerg, Louise Laage and Ovesen, Per Glud and Catalano, Patrick M and Jørgensen, Jan Stener and Jensen, Dorte Møller and Vinter, Christina Anne and Overgaard, Martin},
  title = {Lifestyle Intervention During Pregnancy Is Associated With Favourable Changes of Vitronectin in Women With Obesity: Results From the Randomised LiP Trial},
  journal = {Clinical Obesity},
  year = {2026},
  volume = {16},
  number = {3},
  doi = {10.1111/cob.70085}
}
Kostenlos starten →